Document and Entity Information Document Type Document Quarterly Report Document Period End Date Document Fiscal Year Focus Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Adress Line Two Entity Address, City or Town Entity Address State Or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Period Focus Amendment Flag CONDENSED CONSOLIDATED BALANCE SHEETS Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and cash equivalents Short-Term Investments Short-term investments Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Total prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Other Assets, Noncurrent Other non-current assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses Total accrued expenses Operating Lease, Liability, Current Operating lease liabilities, current portion Less: operating lease liabilities, current portion Liabilities, Current Total current liabilities Operating Lease, Liability, Noncurrent Operating lease liabilities, net of current portion Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies (Note 12) Equity, Attributable to Parent [Abstract] Stockholders' Equity: Common Stock, Value, Issued Common stock, $0.001 par value; 150,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 9,381,344 shares issued and outstanding as of March 31, 2026 and December 31, 2025 Additional Paid in Capital Additional paid-in capital Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income Retained Earnings (Accumulated Deficit) Accumulated deficit Equity, Attributable to Parent Ending balance Beginning balance Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Par value per share (in $ per share) Common Stock, Shares Authorized Common stock, shares authorized (in shares) Common Stock, Shares, Issued Ending balance (in shares) Beginning balance (in shares) Common stock, shares issued (in shares) Common Stock, Shares, Outstanding Common stock, shares outstanding (in shares) CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Operating Income (Loss) [Abstract] Operating expenses: Research and Development Expense Research and development General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Investment Income, Net Interest income Interest income Other Nonoperating Expense Other expense Other expense Net loss Net loss Earnings Per Share, Basic Net loss per share attributable to common stockholders, basic (in dollars per share) Earnings Per Share, Diluted Net loss per share attributable to common stockholders, diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Weighted-average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted-average common shares outstanding, diluted (in shares) Weighted-average common shares outstanding, diluted (in shares) Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Comprehensive loss: OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Unrealized gain(loss) on short-term investments Unrealized (loss) gain on short-term investments Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Statement [Table] Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Additional Paid-In Capital Retained Earnings [Member] Accumulated Deficit AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income Statement [Line Items] Statement Increase (Decrease) in Temporary Equity [Roll Forward] Redeemable Convertible Preferred Stock Temporary Equity, Carrying Amount, Attributable to Parent Redeemable convertible preferred stock ending balance Redeemable convertible preferred stock beginning balance Redeemable convertible preferred stock Temporary Equity, Shares Issued Redeemable convertible preferred stock ending balance (in shares) Redeemable convertible preferred stock beginning balance (in shares) Increase (Decrease) in Stockholders' Equity [Roll Forward] CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Stock Issued During Period, Value, Stock Options Exercised Exercise of stock options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Exercised Exercise of stock options (in shares) APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Stock-based compensation Stock Issued During Period, Shares, Conversion of Convertible Securities Issuance of common stock upon the conversion of Convertible Notes (in shares) CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation, Depletion and Amortization Depreciation and amortization expense Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense Fair Value, Option, Changes in Fair Value, Gain (Loss) Change in fair value of Convertible Notes Change in fair value of Convertible Notes Amount of non-cash expense for lease. Non Cash Lease Expense Non-cash lease expense Accretion (Amortization) of Discounts and Premiums, Investments Accretion of net discounts on short-term investments Interest Expense, Debt Interest expense Interest accrued on Convertible Notes Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Increase (Decrease) in Operating Lease Liability Operating lease liabilities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Payments to Acquire Short-Term Investments Purchases of short-term investments Proceeds from Sale, Maturity and Collection of Short-Term Investments Maturities of short-term investments Net Cash Provided by (Used in) Investing Activities Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Payments of Merger Related Costs, Financing Activities Payments for Merger transaction costs Proceeds from Stock Options Exercised Proceeds from exercise of stock options Net Cash Provided by (Used in) Financing Activities Net cash used in financing activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net decrease in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash and cash equivalents - end of period Cash and cash equivalents - beginning of year Noncash Investing and Financing Items [Abstract] Non-cash investing and financing activities Noncash Merger Related Costs Merger transaction costs included in accounts payable and accrued expenses Nature of the Business and Basis of Presentation Business Description and Basis of Presentation [Text Block] Nature of the Business and Basis of Presentation Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value Measurements Prepaid Expenses and Other Current Assets Other Current Assets [Text Block] Prepaid Expenses and Other Current Assets Intangible Assets Intangible Assets Disclosure [Text Block] Intangible Assets Accrued Expenses The entire disclosure for accrued expenses at the end of the reporting period. Accrued Expenses [Text Block] Accrued Expenses Leases Lessee, Operating Leases [Text Block] Leases Stockholders' Equity (Deficit) Equity [Text Block] Stockholders' Equity (Deficit) Stock-based Compensation Share-Based Payment Arrangement [Text Block] Stock-based Compensation Income Taxes Income Tax Disclosure [Text Block] Income Taxes Net Loss Per Share Earnings Per Share [Text Block] Net Loss Per Share Commitments and Contingencies. Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies No definition available. License Agreements The entire disclosure is about license agreements. License Agreements [Text Block] License Agreements Segment Reporting Segment Reporting Disclosure [Text Block] Segment Reporting Subsequent Event Subsequent Events [Text Block] Subsequent Event Use of Estimates, Policy [Policy Text Block] Use of Estimates Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk and of Significant Suppliers Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Investment, Policy [Policy Text Block] Short-term Investments Comprehensive Income, Policy [Policy Text Block] Comprehensive Income (Loss) New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Not Yet Adopted Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Schedule of information about significant suppliers Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of financial assets and liabilities measured at fair value on a recurring basis Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of changes in the fair value of Level 3 Convertible Notes Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Schedule of prepaid expenses and other current assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of intangible assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of expected remaining amortization expense Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses Lease, Cost [Table Text Block] Schedule of components of lease costs Tabular disclosure of supplemental cash flow information in regarding lease entered by the company. Lessee, Operating Lease, Supplemental Cash Flow Information [Table Text Block] Schedule of supplemental disclosure of cash flow information Tabular disclosure of information regarding weighted-average discount rate and remaining lease term. Lessee, Operating Lease, Weighted-Average Discount Rate and Remaining Lease Term [Table Text Block] Schedule of weighted-average discount rate and remaining lease term Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of maturities of the Company's operating lease liabilities Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of weighted average valuation assumptions for stock options Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of stock option activity Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of classification of stock-based compensation Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Basic and diluted net loss per share attributable to common stockholders Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of potentially dilutive securities excluded from the calculation of diluted net loss per share Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of reconciliation of the company's net income (loss) Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable [Table] Business Acquisition, Equity Interests Issued or Issuable [Line Items] Business Acquisition, Equity Interests Issued or Issuable Concentration Risk [Table] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Supplier Concentration Risk [Member] Supplier concentration risk Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Cost of Goods and Service Benchmark [Member] Operating expenses Accounts Payable [Member] Accounts payable Supplier [Axis] Supplier [Domain] Represents information pertaining to vendors. Vendors [Member] Vendors Represents information pertaining to vendor A. Vendor A [Member] Vendor A Represents information pertaining to vendor B. Vendor B [Member] Vendor B Concentration Risk [Line Items] Summary of Significant Accounting Policies Concentration Risk, Percentage Concentration risk percentage (%) Cash and Cash Equivalent [Table] Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Maximum Maximum Cash and Cash Equivalents [Line Items] Summary of Significant Accounting Policies Money Market Funds, at Carrying Value Amounts held in money market funds Investment Income, Interest Interest income on cash equivalents Debt Securities, Available-for-Sale, Allowance for Credit Loss [Table] Debt Securities, Available-for-Sale, Allowance for Credit Loss [Line Items] Summary of Significant Accounting Policies Amount after accretion (amortization) of discount (premium), of interest income on short-term investments. Investment Income, Interest On Short Term Investments, Net Interest income on short-term investments Debt Securities, Available-for-Sale, Allowance for Credit Loss, Writeoff Impairment or credit losses Fair Value, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Domain] Fair Value, Recurring [Member] Recurring Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] Level 1 Fair Value, Inputs, Level 3 [Member] Level 3 Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Measurements Assets, Fair Value Disclosure [Abstract] Financial assets: Cash Equivalents, at Carrying Value [Abstract] Cash equivalents: Cash and Cash Equivalents, Fair Value Disclosure Money market funds Debt Securities, Available-for-Sale U.S. Treasury Notes Assets, Fair Value Disclosure Total financial assets Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net Assets, transfers in (out of) level 3 Liabilities, Fair Value Disclosure Fair value disclosure of liabilities Fair Value Measurement Inputs and Valuation Techniques [Table] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Represents information pertaining to Legacy Tvardi Convertible Notes converted to Tvardi common stock as part of the Merger. Legacy Tvardi Convertible Notes [Member] Legacy Tvardi Convertible Notes Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurements Debt Instrument, Face Amount Aggregate principal amount Debt Instrument, Interest Rate, Stated Percentage Convertible debt accrued interest rate Convertible Debt Convertible notes outstanding Amount of asset related to consideration paid in advance for research and development expense that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Prepaid Research And Development Expense Prepaid research and development expenses Prepaid Insurance Prepaid insurance Other Prepaid Expense, Current Other prepaid expenses Finite-Lived Intangible Assets, Gross Licensed patent rights Finite-Lived Intangible Assets, Accumulated Amortization Less: accumulated amortization Finite-Lived Intangible Assets, Net Total intangible assets, net Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Intangible Assets Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year 2026 (remaining nine months) Finite-Lived Intangible Asset, Expected Amortization, Year One 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Two 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Three 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Four 2030 Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Finite Lived Intangible Assets Amortization Expense After Year Four Thereafter Intangible Asset, Finite-Lived [Table] Finite-Lived Intangible Assets [Line Items] Intangible Assets Amortization of Intangible Assets Amortization expense Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development expense. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Research And Development, Current Accrued research and development expenses Employee-related Liabilities, Current Accrued employee compensation and benefits Accrued Professional Fees, Current Accrued professional fees Other Accrued Liabilities, Current Other accrued expenses Number of operating leases held as an lessee. Lessee, Operating Lease, Number Number of operating lease Area of Land Area of operating lease Lessee, Operating Lease, Remaining Lease Term Remaining term of lease (years) Lease, Cost [Abstract] Lease costs: Operating Lease, Cost Operating lease cost Variable Lease, Cost Variable lease cost Lease, Cost Total lease costs Operating Lease, Payments Operating cash flows from operating leases Operating Lease, Weighted Average Discount Rate, Percent Weighted-average discount rate Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease term Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Maturities of the Company's operating lease liabilities Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year 2026 (remaining nine months) Lessee, Operating Lease, Liability, to be Paid, Year One 2027 Lessee, Operating Lease, Liability, to be Paid Total lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed interest Operating Lease, Liability Present value of lease liabilities Stock, Class of Stock [Table] Represents information pertaining to the Merger between Cara Therapeutics, Inc. and Tvardi Therapeutics, Inc. Cara Therapeutics, Inc. Merger [Member] The Merger Authorized Cara preferred stock assumed by Tvardi as part of the Merger. Tvardi Preferred Stock [Member] Tvardi Preferred Stock Authorized Cara preferred stock assumed by Tvardi as part of the Merger. Legacy Tvardi Preferred Stock [Member] Legacy Tvardi Preferred Stock Class of Stock [Line Items] Stockholders' Equity (Deficit) Net Loss Per Share Preferred Stock, Shares Authorized Preferred stock authorized Preferred Stock, Par or Stated Value Per Share Preferred stock par value Preferred Stock, Shares Issued Preferred stock shares issued Preferred Stock, Shares Outstanding Preferred stock shares outstanding Number of votes per share of common stock. Common Stock, Number Of Votes Per Share Number of votes per share Common Stock, Dividends, Per Share, Declared Dividend declared Number of shares of preferred stock that were converted into common stock. Stock Issued During Period, Shares, Acquisition, Conversion Of Preferred Stock Number of shares of Legacy Tvardi preferred stock converted (in shares) Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Plan Name [Axis] Plan Name [Domain] Represents information pertaining to 2025 Equity Incentive Plan (the 2025 Plan). Equity Incentive Plan, 2025 [Member] 2025 Equity Incentive Plan Represents information pertaining to 2025 Employee Stock Purchase Plan (the 2025 ESPP). Employee Stock Purchase Plan, 2025 [Member] 2025 Employee Stock Purchase Plan Scenario [Axis] Scenario [Domain] Represents information pertaining to the scenario that option 1 is less than option 2. Scenario Option 1 Lessor [Member] Option 1 Represents information pertaining to the scenario that option 2 is less than option 1. Scenario Option 2 Lessor [Member] Option 2 Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Stock-based Compensation Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Number of shares authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Number of shares available for grant Annual discretionary increase in the number of shares available for grant under the share based payment arrangement, expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share Based Compensation Arrangement By Share Based Payment Award, Number Of Shares Available For Grant, Annual Discretionary Increase, Term Increase in the term of plan Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum Maximum percentage increase of total outstanding fully diluted common stock Common Stock, Capital Shares Reserved for Future Issuance Shares reserved for future issuance Maximum period for which there would be automatic increase in the shares reserved for issuance under the plan expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Share Based Compensation Arrangement By Share Based Payment Award, Shares Reserved For Issuance, Maximum Annual Automatic Increase Term Shares reserved for issuance, maximum annual automatic increase term Shares reserved for issuance increase initial share reserve multiplier used for determining the value of increase under share based payment arrangement. Share Based Compensation Arrangement By Share Based Payment Award, Shares Reserved For Issuance, Increase Initial Share Reserve, Multiplier Shares reserved for issuance increase in initial share Reserve multiplier Share offering period under share based payment arrangement expressed in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Share Based Compensation Arrangement By Share Based Payment Award, Shares Offering Periods Share based payment award shares offering periods Share Price Per share fair value of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free rate Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Outstanding ending Outstanding beginning Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Options granted Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Vested and expected to vest outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted-Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted-average exercise price outstanding ending Weighted-average exercise price outstanding beginning Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Vested and expected to vest outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Weighted-Average Remaining Contractual Term and Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Options outstanding term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Options exercisable term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Vested and expected to vest term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Outstanding intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Options exercisable intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Vested and expected to vest intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average grant-date fair value of options granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Aggregate intrinsic value of options exercised Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Total unrecognized compensation cost of options Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Unrecognized compensation cost, options weighted-average period of recognition Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Research and Development Expense [Member] Research and development General and Administrative Expense [Member] General and administrative Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Stock-based Compensation Share-Based Payment Arrangement, Expense Stock-based compensation Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Income Taxes Current Income Tax Expense (Benefit) Current income tax expense or benefit Deferred Income Tax Expense (Benefit) Deferred income tax expense or benefit Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Numerator: Net Income (Loss) Available to Common Stockholders, Basic Net loss for basic net loss per share attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Diluted Net loss for diluted net loss per share attributable to common stockholders Weighted Average Number of Shares Outstanding, Diluted [Abstract] Denominator: Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Redeemable Convertible Preferred Stock [Member] Preferred stock (as converted to common stock) Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Diluted Net Loss Per Share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive securities Represents the percentage of royalty on net sales during the period. Royalty Percentage On Net Sales Founders' royalty percentage Represents the threshold period after first commercial sales of royalty bearing product up to which royalty obligation are applicable. Threshold Period After First Commercial Sale Of Royalty Bearing Product Number of years after first commercial sale for founders' royalty obligations Disclosure of information about license agreements. License Agreements [Table] Minimum [Member] Minimum Minimum Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. License Agreements [Line Items] License Agreements Amount of annual maintenance fees per license incurred in relation to license agreement during the period. Annual Maintenance Fees Per License Annual maintenance fee per license The amount of accrued maintenance fees. Accrued Maintenance Fees Accrued maintenance fees Amount of annual maintenance fees incurred in relation to license agreement during the period. Annual Maintenance Fees Annual maintenance fee The amount of cash outflow associated with maintenance or milestone fees. Payments for Maintenance or Milestone Fees Payment for maintenance or milestone fees Amount of royalty fees pertaining to license agreement incurred during the period. Royalty Fees Pertain To License Agreement Royalty fees pertaining to license agreement Schedule of Segment Reporting Information, by Segment [Table] Consolidation Items [Axis] Consolidation Items [Domain] Operating Segments [Member] Operating segment Product and Service [Axis] Product and Service [Domain] Represents information pertaining to TTI 101 product. TTI 101 Product [Member] TTI 101 Represents information pertaining to TTI 101 product for hepatocellular carcinoma . TTI 101 For Hepatocellular Carcinoma [Member] HCC Represents information pertaining to TTI 101 product for idiopathic pulmonary fibrosis . TTI 101 For Idiopathic pulmonary Fibrosis [Member] IPF Represents information pertaining to TTI 101 product for pre-clinical, chemistry, manufacturing, control and other. TTI 101 For Pre-clinical, Chemistry Manufacturing, Controls And Other [Member] Pre-clinical, CMC, and other (unallocated) Represents information pertaining to TTI 109 product. TTI 109 Product [Member] TTI 109 Represents information pertaining to unallocated research and development. Unallocated Research And Development [Member] Unallocated Research and Development Segments [Axis] Segments [Domain] Represents information pertaining to single reportable segment. Single Reportable Segment [Member] Single reportable segment Segment Reporting Information [Line Items] Segment Reporting Number of Reportable Segments Number of reportable segments The amount of research and development expenses incurred during the period that is attributable to to product development. Research And Development Expense, Product Direct research and development expenses by program The amount of research and development expenses incurred during the period that is attributable to Personnel costs. Research And Development Expense, Personnel Costs Unallocated research and development expense, personnel costs The amount of research and development expenses incurred during the period that is attributable to consultant fee and other costs Research And Development Expense, Consultant Fees And Other Costs Unallocated research and development expense, consultant fees and other costs Labor and Related Expense General and administrative expenses, personnel costs Other General and Administrative Expense General and administrative expenses, other general and administrative expenses Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event Sale of Stock [Axis] Sale of Stock [Domain] Represents information pertaining to registration statement on Form S-3. Registration Statement On Form S3 [Member] Registration Statement on Form S-3 Represents information pertaining to at-the-market offering. At The Market Offering [Member] At-the-market offering Subsequent Event [Line Items] Subsequent Events Maximum aggregate amount of securities that the registrant may offer and sell pursuant to its shelf registration statement. Maximum Aggregate Offering Price Maximum aggregate offering price Number of prospectus included within a registration statement. Number Of Prospectus In Registration Statement Number of prospectus in registration statement